Influx Health.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MYZ01012
  • NSEID: INFLUX
  • BSEID:
INR
213.60
11.6 (5.74%)
BSENSE

Apr 01

BSE+NSE Vol: 100800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024

Compare Profit and Loss Results of Influx Health.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
104.00
271.00
-167.00
-61.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
104.00
271.00
-167.00
-61.62%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
63.00
159.00
-96.00
-60.38%
Power & Fuel Cost
1.00
8.00
-7.00
-87.50%
Employee Cost
8.00
30.00
-22.00
-73.33%
Operating Expenses
7.00
12.00
-5.00
-41.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
9.00
-8.00
-88.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
84.00
232.00
-148.00
-63.79%
Operating Profit (PBDIT) excl Other Income
20.00
38.00
-18.00
-47.37%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
20.00
44.00
-24.00
-54.55%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
20.00
40.00
-20.00
-50.00%
Depreciation
2.00
4.00
-2.00
-50.00%
Profit Before Taxation & Exceptional Items
17.00
35.00
-18.00
-51.43%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
35.00
-18.00
-51.43%
Provision for Tax
4.00
8.00
-4.00
-50.00%
Profit After Tax
13.00
26.00
-13.00
-50.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
99.00
-83.00
-83.84%
Profit Available for appropriations
29.00
126.00
-97.00
-76.98%
Appropriations
29.00
126.00
-97.00
-76.98%
Equity Dividend (%)
0%
30%
-30.00
Earnings Per Share
7.36
5.57
1.79
32.14%
Profit And Loss - Net Sales
Net Sales 104.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024

Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024